An Analysis of New Drug Development Company in Taiwan: Case Study of TLC, Lumosa and PharmaEngine
碩士 === 臺北醫學大學 === 管理學院生物科技高階管理碩士在職專班 === 106
| Main Authors: | , |
|---|---|
| Other Authors: | |
| Format: | Others |
| Language: | en_US |
| Published: |
2018
|
| Online Access: | http://ndltd.ncl.edu.tw/handle/b85we8 |
| id |
ndltd-TW-106TMC05627002 |
|---|---|
| record_format |
oai_dc |
| spelling |
ndltd-TW-106TMC056270022019-05-16T00:52:47Z http://ndltd.ncl.edu.tw/handle/b85we8 An Analysis of New Drug Development Company in Taiwan: Case Study of TLC, Lumosa and PharmaEngine 台灣生技新藥研發公司開放式創新經營的個案分析-以台灣微脂體、順天醫藥及智擎生技為例 Pei-Jung Lin 林佩蓉 碩士 臺北醫學大學 管理學院生物科技高階管理碩士在職專班 106 Yu-Ren Xiao 蕭育仁 2018 學位論文 ; thesis 50 en_US |
| collection |
NDLTD |
| language |
en_US |
| format |
Others
|
| sources |
NDLTD |
| description |
碩士 === 臺北醫學大學 === 管理學院生物科技高階管理碩士在職專班 === 106 |
| author2 |
Yu-Ren Xiao |
| author_facet |
Yu-Ren Xiao Pei-Jung Lin 林佩蓉 |
| author |
Pei-Jung Lin 林佩蓉 |
| spellingShingle |
Pei-Jung Lin 林佩蓉 An Analysis of New Drug Development Company in Taiwan: Case Study of TLC, Lumosa and PharmaEngine |
| author_sort |
Pei-Jung Lin |
| title |
An Analysis of New Drug Development Company in Taiwan: Case Study of TLC, Lumosa and PharmaEngine |
| title_short |
An Analysis of New Drug Development Company in Taiwan: Case Study of TLC, Lumosa and PharmaEngine |
| title_full |
An Analysis of New Drug Development Company in Taiwan: Case Study of TLC, Lumosa and PharmaEngine |
| title_fullStr |
An Analysis of New Drug Development Company in Taiwan: Case Study of TLC, Lumosa and PharmaEngine |
| title_full_unstemmed |
An Analysis of New Drug Development Company in Taiwan: Case Study of TLC, Lumosa and PharmaEngine |
| title_sort |
analysis of new drug development company in taiwan: case study of tlc, lumosa and pharmaengine |
| publishDate |
2018 |
| url |
http://ndltd.ncl.edu.tw/handle/b85we8 |
| work_keys_str_mv |
AT peijunglin ananalysisofnewdrugdevelopmentcompanyintaiwancasestudyoftlclumosaandpharmaengine AT línpèiróng ananalysisofnewdrugdevelopmentcompanyintaiwancasestudyoftlclumosaandpharmaengine AT peijunglin táiwānshēngjìxīnyàoyánfāgōngsīkāifàngshìchuàngxīnjīngyíngdegèànfēnxīyǐtáiwānwēizhītǐshùntiānyīyàojízhìqíngshēngjìwèilì AT línpèiróng táiwānshēngjìxīnyàoyánfāgōngsīkāifàngshìchuàngxīnjīngyíngdegèànfēnxīyǐtáiwānwēizhītǐshùntiānyīyàojízhìqíngshēngjìwèilì AT peijunglin analysisofnewdrugdevelopmentcompanyintaiwancasestudyoftlclumosaandpharmaengine AT línpèiróng analysisofnewdrugdevelopmentcompanyintaiwancasestudyoftlclumosaandpharmaengine |
| _version_ |
1719172604726607872 |